Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Profiles
Research units
Core Facilities
Sponsored Projects
Publications
Search by expertise, name or affiliation
Management of protease inhibitor-associated hyperlipidemia
S. R. Penzak, S. K. Chuck
UNT System College of Pharmacy
Research output
:
Contribution to journal
›
Article
›
peer-review
38
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Management of protease inhibitor-associated hyperlipidemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Protease Inhibitors
100%
Hyperlipidemias
97%
Fibric Acids
32%
Cholesterol
29%
Gemfibrozil
23%
Virus Diseases
23%
HIV
22%
Fenofibrate
21%
Pravastatin
21%
Ritonavir
20%
Triglycerides
19%
Atorvastatin
19%
Hypertriglyceridemia
18%
Serum
18%
Dyslipidemias
15%
Cytochrome P-450 Enzyme System
15%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
15%
Oxidoreductases
14%
LDL Cholesterol
14%
abacavir
11%
Nelfinavir
11%
Saquinavir
11%
Indinavir
11%
Nevirapine
10%
efavirenz
10%
Lovastatin
10%
Lipids
10%
Simvastatin
9%
Diet Therapy
9%
Cytochrome P-450 CYP3A
9%
Hypercholesterolemia
8%
Drug Interactions
7%
Pancreatitis
7%
Lipid Metabolism
7%
Duration of Therapy
7%
Interferons
7%
HDL Cholesterol
7%
Coronary Disease
7%
Insulin Resistance
6%
Life Style
6%
Atherosclerosis
6%
Diabetes Mellitus
6%
Skeletal Muscle
6%
Fats
6%
Smoking
5%
Tumor Necrosis Factor-alpha
5%
Exercise
5%
Hypertension
5%
Quality of Life
5%
Guidelines
5%
Education
5%
Cytokines
4%
Enzymes
4%
Liver
4%
Mortality
4%
Therapeutics
3%
Pharmaceutical Preparations
3%